13D/13G Filings - Ernexa Therapeutics Inc. (ERNA)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-06-11
8:39 pm
Purchase
2025-06-0913DEterna Therapeutics Inc.
ERNA
Charles Cherington2,779,385
37.900%
1,417,209increase
(+104.04%)
Filing
History
2025-05-15
9:13 pm
Purchase
2025-03-3113GEterna Therapeutics Inc.
ERNA
John D. Halpern398,122
9.600%
55,683increase
(+16.26%)
Filing
History
2025-05-15
4:42 pm
Purchase
2025-03-3113GEterna Therapeutics Inc.
ERNA
Konar Shameek229,020
5.500%
229,020increase
(New Position)
Filing
History
2025-05-14
8:39 pm
Purchase
2025-03-3113GEterna Therapeutics Inc.
ERNA
IAF, LLC217,028
5.200%
38,414increase
(+21.51%)
Filing
History
2025-05-14
2:14 pm
Purchase
2025-03-3113GEterna Therapeutics Inc.
ERNA
Freebird Partners LP414,102
9.900%
71,656increase
(+20.92%)
Filing
History
2025-04-04
10:55 am
Purchase
2025-04-0213DEterna Therapeutics Inc.
ERNA
Charles Cherington1,362,176
32.800%
252,697increase
(+22.78%)
Filing
History
2025-03-05
5:55 pm
Purchase
2024-10-2913DEterna Therapeutics Inc.
ERNA
Charles Cherington1,109,479
32.380%
1,028,644increase
(+1272.52%)
Filing
History
2025-02-14
9:30 pm
Purchase
2024-12-3113GEterna Therapeutics Inc.
ERNA
Nicholas Jason Singer171,000
4.920%
130,968increase
(+327.16%)
Filing
History
2025-02-14
8:36 pm
Purchase
2024-10-2913GEterna Therapeutics Inc.
ERNA
John D. Halpern342,439
9.990%
342,439increase
(New Position)
Filing
History
2025-02-12
5:54 pm
Purchase
2024-10-2913GEterna Therapeutics Inc.
ERNA
IAF, LLC178,614
5.220%
140,150increase
(+364.36%)
Filing
History
2025-01-28
5:31 pm
Purchase
2024-10-2913GEterna Therapeutics Inc.
ERNA
Freebird Partners LP342,446
9.990%
272,214increase
(+387.59%)
Filing
History
2024-01-31
07:05 am
Purchase
2023-12-3113GEterna Therapeutics Inc.
ERNA
John D. Halpern36,726
9.990%
6,574increase
(+21.80%)
Filing
History
2024-01-19
10:31 am
Purchase
2023-12-3113GEterna Therapeutics Inc.
ERNA
Nicholas Jason Singer40,032
9.990%
2,871increase
(+7.73%)
Filing
History
2023-12-22
12:05 pm
Unchanged
2023-12-1413DEterna Therapeutics Inc.
ERNA
Charles Cherington80,835
19.990%
0
(Unchanged)
Filing
History
2023-12-20
3:24 pm
Purchase
2023-12-1413GEterna Therapeutics Inc.
ERNA
IAF, LLC38,464
9.990%
38,464increase
(New Position)
Filing
History
2023-09-08
06:07 am
Unchanged
2023-07-0613GEterna Therapeutics Inc.
ERNA
Nicholas Jason Singer37,161
9.900%
0
(Unchanged)
Filing
History
2023-09-07
5:26 pm
Purchase
2023-07-1313DEterna Therapeutics Inc.
ERNA
Charles Cherington80,835
19.990%
43,000increase
(+113.65%)
Filing
History
2023-08-28
4:57 pm
Purchase
2023-04-0313GEterna Therapeutics Inc.
ERNA
Purchase Capital LLC18,695
5.000%
18,695increase
(New Position)
Filing
History
2023-07-26
5:05 pm
Purchase
2023-04-0313DEterna Therapeutics Inc.
ERNA
Nicholas Jason Singer37,161
9.990%
37,161increase
(New Position)
Filing
History
2023-07-20
7:52 pm
Purchase
2023-07-1413GEterna Therapeutics Inc.
ERNA
Freebird Partners LP70,232
19.990%
23,732increase
(+51.04%)
Filing
History
Goto 0, 1, 2, Next